These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 10544922)
1. Role of intracellular signaling events in ADP-induced platelet aggregation. Daniel JL; Dangelmaier C; Jin J; Kim YB; Kunapuli SP Thromb Haemost; 1999 Oct; 82(4):1322-6. PubMed ID: 10544922 [TBL] [Abstract][Full Text] [Related]
2. Potentiation of thromboxane A2-induced platelet secretion by Gi signaling through the phosphoinositide-3 kinase pathway. Dangelmaier C; Jin J; Smith JB; Kunapuli SP Thromb Haemost; 2001 Feb; 85(2):341-8. PubMed ID: 11246558 [TBL] [Abstract][Full Text] [Related]
3. Evidence for two distinct G-protein-coupled ADP receptors mediating platelet activation. Jantzen HM; Gousset L; Bhaskar V; Vincent D; Tai A; Reynolds EE; Conley PB Thromb Haemost; 1999 Jan; 81(1):111-7. PubMed ID: 10348701 [TBL] [Abstract][Full Text] [Related]
4. Agonist concentration-dependent differential responsivity of a human platelet purinergic receptor: pharmacological and kinetic studies of aggregation, deaggregation and shape change responses mediated by the purinergic P2Y1 receptor in vitro. Maayani S; Schwarz TE; Patel ND; Craddock-Royal BD; Tagliente TM Platelets; 2003; 14(7-8):445-62. PubMed ID: 14713514 [TBL] [Abstract][Full Text] [Related]
5. Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation. Jin J; Kunapuli SP Proc Natl Acad Sci U S A; 1998 Jul; 95(14):8070-4. PubMed ID: 9653141 [TBL] [Abstract][Full Text] [Related]
6. Desensitization of the platelet aggregation response to ADP: differential down-regulation of the P2Y1 and P2cyc receptors. Baurand A; Eckly A; Bari N; Léon C; Hechler B; Cazenave JP; Gachet C Thromb Haemost; 2000 Sep; 84(3):484-91. PubMed ID: 11019976 [TBL] [Abstract][Full Text] [Related]
7. Benzoyl ATP is an antagonist of rat and human P2Y1 receptors and of platelet aggregation. Vigne P; Hechler B; Gachet C; Breittmayer JP; Frelin C Biochem Biophys Res Commun; 1999 Mar; 256(1):94-7. PubMed ID: 10066429 [TBL] [Abstract][Full Text] [Related]
8. P2Y12 ADP receptor-dependent tyrosine phosphorylation of proteins of 27 and 31 kDa in thrombin-stimulated human platelets. Fälker K; Lange D; Presek P Thromb Haemost; 2005 May; 93(5):880-8. PubMed ID: 15886804 [TBL] [Abstract][Full Text] [Related]
9. The P2Y1 receptor is normal in a patient presenting a severe deficiency of ADP-induced platelet aggregation. Léon C; Vial C; Gachet C; Ohlmann P; Hechler B; Cazenave JP; Lecchi A; Cattaneo M Thromb Haemost; 1999 May; 81(5):775-81. PubMed ID: 10365753 [TBL] [Abstract][Full Text] [Related]
10. Diversity of signaling underlying responses mediated by selective activation of the platelet thromboxane A2 (TXA2) receptor; pharmacological and kinetic studies in vitro. Maayani S; Schwarz TE; Patel ND; Craddock-Royal BD; Tagliente TM Platelets; 2003 Sep; 14(6):359-74. PubMed ID: 14602550 [TBL] [Abstract][Full Text] [Related]
12. Role of phosphoinositide 3-kinase beta in platelet aggregation and thromboxane A2 generation mediated by Gi signalling pathways. Garcia A; Kim S; Bhavaraju K; Schoenwaelder SM; Kunapuli SP Biochem J; 2010 Jul; 429(2):369-77. PubMed ID: 20441566 [TBL] [Abstract][Full Text] [Related]
13. P2Y1-receptors in human platelets which are pharmacologically distinct from P2Y(ADP)-receptors. Fagura MS; Dainty IA; McKay GD; Kirk IP; Humphries RG; Robertson MJ; Dougall IG; Leff P Br J Pharmacol; 1998 May; 124(1):157-64. PubMed ID: 9630355 [TBL] [Abstract][Full Text] [Related]
14. Activation of the alpha(2A)-adrenoceptor mediates deceleration of the deaggregation component of the response to ADP or 5-HT in human platelets in vitro. Maayani S; Schwarz T; Craddock-Royal B; Tagliente TM Platelets; 2001 Sep; 12(6):359-75. PubMed ID: 11672475 [TBL] [Abstract][Full Text] [Related]
15. Molecular basis for ADP-induced platelet activation. II. The P2Y1 receptor mediates ADP-induced intracellular calcium mobilization and shape change in platelets. Jin J; Daniel JL; Kunapuli SP J Biol Chem; 1998 Jan; 273(4):2030-4. PubMed ID: 9442040 [TBL] [Abstract][Full Text] [Related]
16. Platelet activation by ADP: the role of ADP antagonists. Gachet C Ann Med; 2000 Dec; 32 Suppl 1():15-20. PubMed ID: 11209975 [TBL] [Abstract][Full Text] [Related]
17. A selective role for phosphatidylinositol 3,4,5-trisphosphate in the Gi-dependent activation of platelet Rap1B. Lova P; Paganini S; Hirsch E; Barberis L; Wymann M; Sinigaglia F; Balduini C; Torti M J Biol Chem; 2003 Jan; 278(1):131-8. PubMed ID: 12407113 [TBL] [Abstract][Full Text] [Related]
18. P2Y12, a new platelet ADP receptor, target of clopidogrel. Herbert JM; Savi P Semin Vasc Med; 2003 May; 3(2):113-22. PubMed ID: 15199474 [TBL] [Abstract][Full Text] [Related]
19. The P2Y1 receptor is essential for ADP-induced shape change and aggregation in mouse platelets. Kim YB; Jin J; Dangelmaier C; Daniel JL; Kunapuli SP Platelets; 1999; 10(6):399-406. PubMed ID: 16801119 [TBL] [Abstract][Full Text] [Related]